4//SEC Filing
COLTHARP DOUGLAS E 4
Accession 0001127602-25-012782
CIK 0000785161other
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 1:24 PM ET
Size
18.3 KB
Accession
0001127602-25-012782
Insider Transaction Report
Form 4
COLTHARP DOUGLAS E
EVP, Chief Financial Officer
Transactions
- Exercise/Conversion
Encompass Health Common Stock
2025-04-29$29.06/sh+16,075$467,140→ 76,410 total - Sale
Encompass Health Common Stock
2025-04-29$114.78/sh−26,239$3,011,712→ 77,671 total - Exercise/Conversion
Encompass Health Common Stock
2025-04-29$32.94/sh+27,500$905,850→ 103,910 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2025-04-29−16,075→ 0 totalExercise: $29.06From: 2017-02-26Exp: 2026-02-26→ Encompass Health Common Stock (16,075 underlying) - Sale
Encompass Health Common Stock
2025-04-29$115.51/sh−13,402$1,548,065→ 64,269 total - Sale
Encompass Health Common Stock
2025-04-29$116.36/sh−3,934$457,760→ 60,335 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2025-04-29−27,500→ 27,694 totalExercise: $32.94From: 2019-10-28Exp: 2026-10-28→ Encompass Health Common Stock (27,500 underlying)
Holdings
- 65,229(indirect: By Spouse)
Encompass Health Common Stock
- 125,631(indirect: By Trust)
Encompass Health Common Stock
Footnotes (5)
- [F1]This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.22 to $115.21, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
- [F2]This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.22 to $116.21, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
- [F3]This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.22 to $116.57, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
- [F4]The reporting person disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- [F5]The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc.
Documents
Issuer
Encompass Health Corp
CIK 0000785161
Entity typeother
Related Parties
1- filerCIK 0001186879
Filing Metadata
- Form type
- 4
- Filed
- Apr 29, 8:00 PM ET
- Accepted
- Apr 30, 1:24 PM ET
- Size
- 18.3 KB